Healthcare ratings - upgrades/downgrades

NG_NM

Healthcare ratings - upgrades/downgrades[size=0.95em]Jul 22 2016, 08:40 ET | By: [color=rgb(2, 73, 153) !important]Douglas W. House, SA News Editor

Johnson & Johnson (NYSE:JNJ) upgraded to Buy from Hold by Argus Research. Price target raised to $145 (16% upside) from $130.

Humana (NYSE:HUM) upgraded to Buy from Hold by Jefferies. Price target raised to $210 (22% upside) from $199.

Teva Pharmaceutical Industries (NYSE:TEVA) upgraded to Buy from Hold by HSBC. Price target raised to $65 (19% upside) from $61.

Relypsa (NASDAQ:RLYP) downgraded to Neutral from Buy by Citigroup. Price target raised to $32 (0% upside) from $25.

Evoke Pharma (NASDAQ:EVOK) downgraded to Hold from Buy by Noble Financial. Downgraded to Hold from Buy by Brean Capital. Downgraded to Neutral from Buy by Rodman & Renshaw.

Merck (NYSE:MRK) downgraded to Market Perform from Outperform with a $62 (5% upside) price target by BMO Capital.

St. Jude Medial (NYSE:STJ) downgraded to Neutral from Outperform by Wedbush. Price target raised to $84 (3% upside) from $70.

Teva Pharmaceutical Industries (TEVA) downgraded to Neutral from Buy by Goldman Sachs. Price target lowered to $60 (10% upside) from $70.

lakeFJ

NG_NM

lakeFJ 发表于 2016-7-22 08:26 AM

多交流你的选择。 谢谢。

NG_NM

lakeFJ 发表于 2016-7-22 08:26 AM

好像其他医险公司也有类似消息。

Hutong9999

section rotation to IBB , looks decent

lakeFJ

NG_NM 发表于 2016-7-22 07:28 AM
多交流你的选择。 谢谢。

Thanks, I will.

Enjoy weekend please!

rightonmoney

风行过

先看看大盘往哪走。如果真上云霄了，值得跟进。

NG_NM

风行过 发表于 2016-7-23 01:56 PM
先看看大盘往哪走。如果真上云霄了，值得跟进。

行业表现经常和三大指数不同。